| We have 30 articles this week. #XtalPi and #CK Life Sciences to collaborate in AI-empowered #tumour vaccine research and development, opening a new paradigm for scientific innovation. #Peijia Medical Limited and #inQB8 Medical Technologies, LLC report Successful First-in-Human implantation of MonarQ Transcatheter Tricuspid Valve Replacement System. #Health Canada Authorizes POLIVY® (polatuzumab vedotin for injection) for the First-Line Treatment of Adults with Large #B-Cell Lymphoma #FDA Grants Priority Review to #Takeda's #Dengue Vaccine #Site Enablement Platforms Can Accelerate Clinical Trials by 6 Weeks and Reduce Costs by Over $1M. #Nordic Nanovector: Invitation to webcast regarding the proposed merger with #APIM Therapeutics. #Lunit, #CARPL.ai Partner to Accelerate AI-Powered Medical Imaging. #ResMed Completes Acquisition of #MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions. #Health tech firm #CardieX acquires cardiovascular sensor company #Blumio |
| Editor's Choice |
|
1.
|
Roundup: Indian Startups Score New Fundings and More Briefs |
|
2.
|
Health Management Platform Novi Health Raises $5M in Series A Funding Round |
|
3.
|
State AGs urge Apple to Better Protect Reproductive Health Data |
|
4.
|
Tiziana Announces Publication of a Peer-Reviewed Article on the Intranasal Administration of Foralumab Demonstrating Modulated Effector CD8+ T cell Function and an Induced T Cell Regulatory Response in Human Subjects |
|
5.
|
Odyssey Health, Inc. Provides Update on Company and the Progress of Concussion Drug Development |
| Top 09 M&A Transactions |
|
6.
|
XtalPi and CK Life Sciences to Collaborate in AI-Empowered Tumour Vaccine Research and Development, Opening a New Paradigm for Scientific Innovation |
|
7.
|
Peijia Medical Limited and inQB8 Medical Technologies, LLC report Successful First-in-Human implantation of MonarQ Transcatheter Tricuspid Valve Replacement System |
|
8.
|
Health Canada Authorizes POLIVY® (polatuzumab vedotin for injection) for the First-Line Treatment of Adults With Large B-Cell Lymphoma |
|
9.
|
Health Tech Firm CardieX Acquires Cardiovascular Sensor Company Blumio |
|
10.
|
FDA Grants Priority Review to Takeda’s Dengue Vaccine |
|
11.
|
Arvinas’ Experimental Breast Cancer Drug Fails to Impress Analysts |
|
12.
|
Novartis and MMV Move to Pivotal Study with New Class of Drug for Malaria |
|
13.
|
Oxurion Further Improves THR-149 Patent Position |
|
14.
|
Provider Burnout Has Leveled Out in 2022; Staffing Shortages Rises, KLAS Reports |
| Top 4 Venture Funding |
|
15.
|
Site Enablement Platforms Can Accelerate Clinical Trials by 6 Weeks and Reduce Costs by Over $1M |
|
16.
|
Nordic Nanovector: Invitation to wWebcast Regarding Proposed Merger with APIM Therapeutics |
|
17.
|
PayZen Nabs $200M for Personalized, No-Cost Patient Financing |
|
18.
|
Biocare Medical Acquires Empire Genomics, Expanding Molecular Portfolio to Over 1 Million Biomarkers and Adding Rapid Biomarker Development to Lead Cancer Research |
| Top 4 Partnerships Announcements |
|
19.
|
Lunit, CARPL.ai Partner to Accelerate AI-Powered Medical Imaging |
|
20.
|
ResMed Completes Acquisition of MEDIFOX DAN, A German Leader in Out-of-Hospital Care Management Software Solutions |
|
21.
|
XOMA Acquires Royalty and Milestone License to Ebopiprant, a Preterm Labor Asset, Being Developed by Organon |
|
22.
|
Graybug and CalciMedica Enter into Definitive Merger Agreement |
|
Read More Corporate Development and M&A Activity |
|
5760 Legacy Dr, B3-405,
+1 469-270-3311